Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	52.70	-35.54	-75.13
Graham Fair Price	41.42	0.20	0.14
PEG	-95.96	< 0.005	< 0.005
Price/Book	40.00	1.21	0.86
Price/Cash Flow	-100.00	-4.10	0.00
Prices/Earnings	30.00	-0.05	-0.07
Price/Sales	-30.00	1.19	1.70
Price/FCF	-100.00	-4.10	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	118.13	0.28	0.13
Operating Margin	-2.20	-0.73	-0.72
ROA	-100.00	-0.23	-0.12
ROE	-2.96	-5.93	-100.00
ROIC	-0.02	-0.05	-102.85
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	16.85
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.46	-1.04	-126.06
EPS QOQ	-2.62	-0.93	64.28
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	-0.44	1.00	128.71
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3227.38	1961.27	-39.23
Days Sales Outstanding (DSO)	86.40	77.35	-10.47
Inventory Turnover	0.03	0.05	64.56
Debt/Capitalization	0.93	0.93	-0.04
Quick Ratio	0.03	0.04	60.09
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.02	0.02	< 0.005
Cash	< 0.005	< 0.005	3.91
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	< 0.005	-100.00
Revenue	< 0.005	0.02	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.69	0.69	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-70.65	-32.63	53.82
Naive Interpretation	Member

06 - Financial Health · Bad

Rating